digital health investment
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
Epicore Biosystems expands Series B to $32 million to advance sweat-sensing wearable technology.
The company will fund and develop companies that focus on eight key areas in healthcare and create AI/genAI technologies that help advance those areas.
OneCell Diagnostics scores $16 million for genomics-based precision oncology and dannce.ai, a phenotyping platform to digitize clinical assessments, secures $2.6 million.
The funding includes $4.5 billion for the firm's core VC funds, $1.5 billion for its Creation strategy and $2 billion for separately managed accounts.
The company will use the funds to launch its diagnostics division and expand its offerings under the helm of its new chief operating officer.
Ben Robbins, general partner at GV, wraps up MobiHealthNews' investment series by unveiling the crucial traits digital health companies must possess to secure funding in a highly competitive market.
Brigham Hyde, CEO of Atropos Health, provides the vendor perspective on digital health funding and pitching to venture capitalists in an ever-changing market.
Sonny Shergill, vice president of commercial digital health at AstraZeneca, highlights pharma's perspective on digital health investments and partnerships for sector growth.
Matt Cybulsky, LBMC practice leader for healthcare AI, value-based care and product innovation, discusses consulting digital health companies on seeking investment.